Plunkett Research Online: AEterna Zentaris Inc

AETERNA ZENTARIS INC (AEZS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a.....



AEterna Zentaris Inc
Ticker: AEZS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 843-900-3223
Fax:
Address: c/o Norton Rose Fulbright Canada, LLP
222 Bay Street
Suite 3000, PO Box 53
Toronto, ON M5K 1E7 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Development
Biopharmaceutical Development
Biopharmaceutical Licensing
Contacts Description
Klaus Paulini CEO/Director/Managing Director, Subsidiary/President
Leslie Auld CFO/Senior VP
See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Macimorelin
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: